Acute and Chronic Placental Abnormalities in a Multicenter Cohort of Newborn Infants with Hypoxic-Ischemic Encephalopathy.


Journal

The Journal of pediatrics
ISSN: 1097-6833
Titre abrégé: J Pediatr
Pays: United States
ID NLM: 0375410

Informations de publication

Date de publication:
Oct 2021
Historique:
received: 29 01 2021
revised: 28 05 2021
accepted: 14 06 2021
pubmed: 19 6 2021
medline: 30 11 2021
entrez: 18 6 2021
Statut: ppublish

Résumé

To examine the frequency of placental abnormalities in a multicenter cohort of newborn infants with hypoxic-ischemic encephalopathy (HIE) and to determine the association between acuity of placental abnormalities and clinical characteristics of HIE. Infants born at ≥36 weeks of gestation (n = 500) with moderate or severe HIE were enrolled in the High-dose Erythropoietin for Asphyxia and Encephalopathy Trial. A placental pathologist blinded to clinical information reviewed clinical pathology reports to determine the presence of acute and chronic placental abnormalities using a standard classification system. Complete placental pathologic examination was available for 321 of 500 (64%) trial participants. Placental abnormalities were identified in 273 of 321 (85%) and were more common in infants ≥40 weeks of gestation (93% vs 81%, P = .01). A combination of acute and chronic placental abnormalities (43%) was more common than either acute (20%) or chronic (21%) abnormalities alone. Acute abnormalities included meconium staining of the placenta (41%) and histologic chorioamnionitis (39%). Chronic abnormalities included maternal vascular malperfusion (25%), villitis of unknown etiology (8%), and fetal vascular malperfusion (6%). Infants with chronic placental abnormalities exhibited a greater mean base deficit at birth (-15.9 vs -14.3, P = .049) than those without such abnormalities. Patients with HIE and acute placental lesions had older mean gestational ages (39.1 vs 38.0, P < .001) and greater rates of clinically diagnosed chorioamnionitis (25% vs 2%, P < .001) than those without acute abnormalities. Combined acute and chronic placental abnormalities were common in this cohort of infants with HIE, underscoring the complex causal pathways of HIE. ClinicalTrials.gov: NCT02811263.

Identifiants

pubmed: 34144032
pii: S0022-3476(21)00553-9
doi: 10.1016/j.jpeds.2021.06.023
pii:
doi:

Substances chimiques

Erythropoietin 11096-26-7

Banques de données

ClinicalTrials.gov
['NCT02811263']

Types de publication

Clinical Trial, Phase III Journal Article Multicenter Study Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

190-196

Subventions

Organisme : NINDS NIH HHS
ID : U01 NS092764
Pays : United States

Informations de copyright

Copyright © 2021. Published by Elsevier Inc.

Auteurs

Lina Chalak (L)

Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, TX. Electronic address: Lina.chalak@utsouthwestern.edu.

Raymond W Redline (RW)

Department of Pathology, University Hospitals Cleveland Medical Center, Cleveland, OH.

Amy M Goodman (AM)

Department of Neurology, University of California San Francisco, San Francisco, CA.

Sandra E Juul (SE)

Division of Neonatology, Department of Pediatrics, University of Washington School of Medicine, Seattle, WA.

Taeun Chang (T)

Department of Neurology, Children's National Hospital, George Washington School of Medicine, Washington, DC.

Toby D Yanowitz (TD)

Division of Newborn Medicine, Department of Pediatrics, University of Pittsburgh School of Medicine, Children's Hospital of Pittsburgh of UPMC and Magee Womens Hospital of UPMC, Pittsburgh, PA.

Nathalie Maitre (N)

Department of Pediatrics and Research Institute, Nationwide Children's Hospital, Columbus, OH.

Dennis E Mayock (DE)

Division of Neonatology, Department of Pediatrics, University of Washington School of Medicine, Seattle, WA.

Andrea L Lampland (AL)

Department of Neonatology, Children's Minnesota, St Paul, MN.

Ellen Bendel-Stenzel (E)

Division of Neonatal Medicine, Department of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, MN.

David Riley (D)

Department of Pediatrics, Cook Children's Medical Center, Texas Christian University and University of North Texas Health Science Center School of Medicine, Fort Worth, TX.

Amit M Mathur (AM)

Department of Pediatrics/Neonatal-Perinatal Medicine, Saint Louis University School of Medicine, St Louis, MO.

Rakesh Rao (R)

Division of Newborn-Medicine, Department of Pediatrics, Washington University School of Medicine, St Louis, MO.

Krisa P Van Meurs (KP)

Division of Neonatal and Developmental Medicine, Stanford University School of Medicine, Palo Alto, CA.

Tai-Wei Wu (TW)

Division of Neonatology, Fetal and Neonatal Institute, Children's Hospital Los Angeles, Los Angeles, CA; Department of Pediatrics, Keck School of Medicine, University of Southern California, Los Angeles, CA.

Fernando F Gonzalez (FF)

Department of Pediatrics, University of California San Francisco, San Francisco, CA.

John Flibotte (J)

Division of Neonatology, Children's Hospital of Philadelphia, Philadelphia, PA; Department of Pediatrics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA.

Ulrike Mietzsch (U)

Division of Neonatology, Department of Pediatrics, University of Washington School of Medicine, Seattle, WA; Division of Neonatal-Perinatal Medicine, Department of Pediatrics, Indiana University School of Medicine, Indianapolis, IN.

Gregory M Sokol (GM)

Division of Neonatal-Perinatal Medicine, Department of Pediatrics, Indiana University School of Medicine, Indianapolis, IN.

Kaashif A Ahmad (KA)

Pediatrix Medical Group of San Antonio, San Antonio, TX.

Mariana Baserga (M)

Division of Neonatology, Department of Pediatrics, University of Utah, Salt Lake City, UT.

Joern-Hendrik Weitkamp (JH)

Department of Pediatrics, Vanderbilt University Medical Center, Nashville, TN.

Brenda B Poindexter (BB)

Division of Neonatology, Department of Pediatrics, Children's Healthcare of Atlanta and Emory University, Atlanta, GA.

Bryan A Comstock (BA)

Department of Biostatistics, University of Washington, Seattle, WA.

Yvonne W Wu (YW)

Department of Neurology, University of California San Francisco, San Francisco, CA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH